Kelly W. Burak

1 ta ish

Heritage Medical Research Clinic -University of Calgary, Calgary, Alberta,

1. 49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIAL

   Jordi Bruix, Thierry Poynard, Massimo Colombo +16

   MaqolaHepatocellular Carcinoma Treatment and PrognosisJournal of Hepatology20090 iqtibos

   ABIABI:AkademIndex/openalex/2009.article.000125